MEYRA appoints Dr. Soenke Roessing as CEO

Porta Westfalica – 22 October 2025 – Dr. Soenke Roessing will assume the role as CEO at Meyra Group, a leading European provider of innovative mobility and rehabilitation solutions, on 1 November 2025. Dr. Roessing succeeds Bernd Fabian, who will pursue new endeavors after more than four highly successful years at Meyra.

Under the leadership of Bernd Fabian, Meyra has evolved into one of the leading international players in the industry for medical mobility solutions. Employees and shareholders of Meyra extend their sincere appreciation to Mr. Fabian for his outstanding commitment and significant contributions.

Dr. Soenke Roessing brings extensive industry and leadership experience in the healthcare and mobility sector. Most recently, he served as CEO of Detax GmbH, a leading material manufacturer of medical products for dentistry and hearing care. Prior to that, he spent around 14 years in various leadership roles at the globally operating Ottobock Group. During his time at Ottobock, he played a key role in advancing the company’s mobility products and patient care businesses, and in establishing its exoskeleton division as a global market leader.

“Meyra has an impressive track record and holds a leading position in today’s market. Over the past years, Bernd Fabian has played a key role in driving Meyra’s positive development even in economically challenging times. We thank him for his contributions and wish him all the best for the future,” said Dr. Holger Kleingarn, Chairman of the Advisory Board of the Meyra Group.

Dr. Kleingarn continued: “With Dr. Soenke Roessing, we have attracted an exceptionally experienced and entrepreneurial CEO for Meyra who is deeply connected within the mobility market and has a profound understanding of our customers in Germany and abroad. With his strategic vision, deep industry expertise, and strong results orientation, he will shape and drive the next phase of growth and positive development of Meyra.”